MiNK Therapeutics, Inc. (INKT) Capital expenditures 2021–2024
MiNK Therapeutics, Inc. (INKT) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$73,561FY2024 · since FY2021: $95,212 → $73,561
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $73,561 | -70.6% |
| FY2023 | $250,046 | +0.4% |
| FY2022 | $248,983 | +161.5% |
| FY2021 | $95,212 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice